SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001818382-24-000102
Filing Date
2024-06-13
Accepted
2024-06-13 16:50:01
Documents
14
Period of Report
2024-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K huma-20240611.htm   iXBRL 8-K 43191
  Complete submission text file 0001818382-24-000102.txt   212250

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT huma-20240611.xsd EX-101.SCH 2301
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT huma-20240611_def.xml EX-101.DEF 15875
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT huma-20240611_lab.xml EX-101.LAB 27912
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT huma-20240611_pre.xml EX-101.PRE 16602
17 EXTRACTED XBRL INSTANCE DOCUMENT huma-20240611_htm.xml XML 4275
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 241041921
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)